SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,830 | -21.9% | 4,350 | 0.0% | 0.00% | – |
| Q2 2022 | $8,744 | -13.7% | 4,350 | 0.0% | 0.00% | – |
| Q1 2022 | $10,136 | -23.5% | 4,350 | +52.6% | 0.00% | – |
| Q4 2021 | $13,253 | -39.1% | 2,850 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $21,746 | -21.3% | 2,850 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $27,617 | -31.1% | 2,850 | -41.2% | 0.00% | -50.0% |
| Q1 2021 | $40,110 | +4.0% | 4,850 | -14.2% | 0.00% | 0.0% |
| Q4 2020 | $38,561 | -53.1% | 5,650 | -23.4% | 0.00% | -60.0% |
| Q3 2020 | $82,231 | +141.4% | 7,375 | +35.9% | 0.01% | +150.0% |
| Q2 2020 | $34,069 | +2739.1% | 5,425 | +985.0% | 0.00% | – |
| Q4 2018 | $1,200 | -81.8% | 500 | -66.7% | 0.00% | -100.0% |
| Q3 2018 | $6,600 | -38.9% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $10,800 | +39.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,725 | +1.6% | 1,500 | -25.0% | 0.00% | 0.0% |
| Q4 2017 | $7,600 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |